Skip to main content
Caplight Logo









CytoTronics

CytoTronics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://cytotronics.com/

Last Round

Seed

Sep 5, 2024

Total Funding Raised

$22.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CytoTronics is a biotechnology company that develops semiconductor-based systems for studying cell biology, enabling researchers to visualize live cell function at scale and obtain real-time data on cell behavior to explore complex biological processes in greater detail.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Semiconductors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

live cell monitoringphenotypic screeningdrug discoveryhigh-throughput screeningbiotech hardwarelab automationsemiconductor biotechnologycell biology researchbio-semiconductorscellular imagingassay developmentlab-on-a-chipbio-sensingmicrofluidicsbiotech consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CytoTronics Comparables

Compare CytoTronics with similar companies based on industry and business-model similarity.

CytoTronics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3Brain AG
83%
MaxWell Biosystems
81%
Axion BioSystems
80%

CytoTronics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 5, 2024
SeedApr 28, 2022

CytoTronics Investors

Notable investors and investment history

CytoTronics investors
InvestorRounds
Legend StarSeed
LYFE CapitalSeed
BoxOne VenturesSeed
Anzu PartnersSeed
Draper AssociatesSeed
RIT Venture FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 181% MoM, reaching 3.2K.

  • Jan 26, 2026

    Acquired high-throughput, high-density CMOS MEA technology assets from Axion BioSystems.

CytoTronics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CytoTronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CytoTronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range8
Year Founded2021
Last FundingSep 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?